Researchers to compare PET, CT for predicting tumor response

08/1/2008 | 7th Space Interactive

Dutch scientists plan to compare the ability of FDG-PET and CT scans to predict whether tumors in patients with curable esophageal cancer will respond to neoadjuvant chemoradiotherapy. FDG-PET is capable of measuring the metabolic changes in tumor tissue, which earlier data have found to be an accurate predictor of tumor response.

View Full Article in:

7th Space Interactive

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA